Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1471-1480 of 2905 for cancer

Edit search filters
  1. A Study Of Pomalidomide, Ixazomib Citrate, And Dexamethasone In Treating Patients With Previously Treated Multiple Myeloma Or Plasma Cell Leukemia

    Rochester, MN

  2. Study Of Pembrolizumab (MK-3475) In Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)

    Rochester, MN

  3. The Cancer Connected Access And Remote Expertise Beyond Walls Program To Provide In-Home Cancer Treatment And Improve Treatment Satisfaction In Cancer Patients Living In The Florida Panhandle And Surrounding Areas

    Jacksonville, FL

  4. A Study To Evaluate The Effectiveness Of M7824 Monotherapy In Locally Advanced Or Metastatic Biliary Tract Cancer (Cholangiocarcinoma And Gallbladder Cancer)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. GB5121 In Adult Subjects With Relapsed/Refractory CNS Lymphoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. A Study Of MT-0169 In Participants With Relapsed Or Refractory Multiple Myeloma Or Non-Hodgkin Lymphoma

    Jacksonville, FL, Rochester, MN

  7. Lenalidomide Plus Rituximab Followed By Lenalidomide Versus Rituximab Maintenance For Relapsed/Refractory Follicular, Marginal Zone Or Mantle Cell Lymphoma.

    Rochester, MN

  8. Study Of Orally Administered AG-120 In Subjects With Advanced Hematologic Malignancies With An IDH1 Mutation

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  9. Cyclophosphamide, Ixazomib, And Dexamethasone In Treating Patients With Previously Untreated Symptomatic Multiple Myeloma

    Scottsdale/Phoenix, AZ, Rochester, MN

  10. A Study To Evaluate MEDI2228 In Subjects With Relapsed/ Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer